Next-generation balloon-expandable transcatheter heart valve: the SAPIEN 3 Ultra valve.


Journal

Future cardiology
ISSN: 1744-8298
Titre abrégé: Future Cardiol
Pays: England
ID NLM: 101239345

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 21 1 2021
medline: 29 1 2022
entrez: 20 1 2021
Statut: ppublish

Résumé

The next generation SAPIEN 3 Ultra (Edwards Lifesciences, CA, USA) builds on the success of the SAPIEN 3 (S3) transcatheter heart valve. The textured polyethylene terephthalate external skirt is 40% taller than the S3 valve skirt. The Edwards Commander delivery system and Edwards eSheath remain unchanged from S3 with proven results regarding valve deliverability and low rates of vascular complications.

Identifiants

pubmed: 33470845
doi: 10.2217/fca-2020-0001
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

811-816

Auteurs

Andrew Chatfield (A)

Centre for Heart Valve Innovation, Vancouver, BC, V6Z 1Y6, Canada.

Janarthanan Sathananthan (J)

Centre for Heart Valve Innovation, Vancouver, BC, V6Z 1Y6, Canada.

David A Wood (DA)

Centre for Heart Valve Innovation, Vancouver, BC, V6Z 1Y6, Canada.

John G Webb (JG)

Centre for Heart Valve Innovation, Vancouver, BC, V6Z 1Y6, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH